IMCD NV banner

IMCD NV
Investor Relations

IMCD is a specialty chemicals distributor. It buys ingredients and raw materials from chemical producers and sells them to manufacturers that need specific formulations, such as companies in food, pharmaceuticals, personal care, coatings, plastics, and industrial products. It is not a basic commodity trader; it focuses on harder-to-match specialty products that need technical knowledge and careful handling. The company makes money mainly by reselling these products through its distribution network. In many cases, it also adds value by helping customers choose the right ingredients, combining materials into workable formulas, handling local storage and logistics, and dealing with regulatory and technical requirements. Its customers are manufacturers that want a reliable local partner who can supply smaller, more tailored orders and help solve formulation problems. What makes IMCD’s business different is that it sits in the middle of the supply chain between global chemical makers and end-user manufacturers. Producers use IMCD to reach many smaller and more specialized customers across countries, while customers use IMCD to get access to a broad product range plus local technical support. That mix of distribution, application expertise, and customer service is the core of its business model.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Apr 30, 2026
AI Summary
Q1 2026

Solid quarter: IMCD said Q1 2026 was a solid start to the year, but management was not satisfied with the reported outcome because of tough comparisons and foreign exchange headwinds.

Cash strength: Free cash flow rose to EUR 121 million and cash conversion margin was almost 91%, which management highlighted as a strong result.

Margin pressure: Gross profit increased 1% on a constant-currency basis, but EBITA was lower because weaker gross profit was not fully offset by lower costs.

Cautious outlook: Management said the company is seeing a solid start to Q2, but remains positive yet cautious because the Middle East conflict could hurt end-demand and extend supply chain disruption.

Pricing and shortages: IMCD said supplier price increases have become widespread, especially outside North America, but it has not yet seen shortages; the market narrative around shortages is rising, though.

M&A adds scale: The company completed two acquisitions in the quarter, in South Korea and in the U.K. and Ireland, strengthening beauty, personal care, food, and nutrition capabilities.

Key Financials
Gross profit
EUR 312 million
EBITA
EUR 130 million
Free cash flow
EUR 121 million
Cash conversion margin
almost 91%
Gross margin
24.6%
Operating EBITA margin
10.2%
Conversion margin
41.6%
Net result
EUR 63 million
Cash earnings per share
EUR 1.46
Holding costs
0.6% of revenue
Leverage
2.8x
Loan documentation leverage
2.7x LTM EBITDA
Holding company costs
0.6% of revenue
Earnings Call Recording
Other Earnings Calls
2026
2025
2024
2022
2021
2020
2019
2018

Management

Ms. Valerie Diele-Braun
CEO & Member of Management Board
No Bio Available
Mr. Hans J. J. Kooijmans CPA
CFO & Member of Management Board
No Bio Available
Mr. Marcus Jordan
COO & Member of Management Board
No Bio Available
Laurens Dalmijin
General Counsel
No Bio Available
Mr. Olivier Champault
President of IMCD France & Business and Group Director of Advanced Materials
No Bio Available
Ms. Swapna Kattewar
Head of Global Regulatory Questionnaire Centre
No Bio Available
Andreas Igerl
President of APAC
No Bio Available
Mr. Arturo Hoyo
Managing Director of IMCD Mexico
No Bio Available
Cecile Westerhuis
Company Secretary
No Bio Available

Contacts

Address
ZUID-HOLLAND
Rotterdam
Wilhelminaplein 32
Contacts
+31102908684.0
www.imcdgroup.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett